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PAfrican-American Women Have a Higher
Risk for Developing Peripartum Cardiomyopathy
Mindy B. Gentry, MD,* James K. Dias, PHD,† Antonio Luis, MD,* Rakesh Patel, MD,*
John Thornton, MD,* Guy L. Reed, MD*‡
Augusta, Georgia; and Memphis, Tennessee
Objectives The purpose of this study was to assess whether African-American women are at increased risk of having peri-
partum cardiomyopathy.
Background Peripartum cardiomyopathy is a heart disease of unknown cause that affects young women, often with devastat-
ing consequences. The frequency of peripartum cardiomyopathy varies markedly between African and non-
African regions.
Methods A case-control study was performed at a regional center that provides medical care to a racially heterogeneous
population. For each case, 3 healthy control patients were randomly selected who delivered babies within the
same month.
Results African-American women had a 15.7-fold higher relative risk of peripartum cardiomyopathy than non–African
Americans (odds ratio [OR]: 15.7, 95% confidence interval [CI]: 3.5 to 70.6). Other significant univariate risk fac-
tors were hypertension (OR: 10.8, 95% CI: 2.6 to 44.4), being unmarried (OR: 4.2, 95% CI: 1.4 to 12.3), and hav-
ing had 2 previous pregnancies (OR: 2.9, 95% CI: 1.1 to 7.4). African-American ethnicity remained a significant
risk factor for peripartum cardiomyopathy when other risk factors were considered in multivariable (OR: 31.5,
95% CI: 3.6 to 277.6) and stratified analyses (OR: 12.9 to 29.1, p  0.001). Although the frequency of peripar-
tum cardiomyopathy (185 of 100,000 deliveries) at this center was higher than in previous U.S. reports, it was
comparable to the frequency in countries with more women of African descent (100 to 980 of 100,000). Analy-
sis of other U.S. studies confirmed that the frequency of peripartum cardiomyopathy was significantly higher
among African-American women.
Conclusions African-American women have significantly higher odds of having peripartum cardiomyopathy that could not be
explained by several other factors. Further research will be necessary to determine the potential environmental
and/or genetic factors associated with African descent that confer this risk. (J Am Coll Cardiol 2010;55:
654–9) © 2010 by the American College of Cardiology Foundation
ublished by Elsevier Inc. doi:10.1016/j.jacc.2009.09.043R
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veripartum cardiomyopathy is a major cause of heart
ailure (HF) and cardiovascular mortality among women
f child-bearing age. It occurs in women without pre-
xisting heart disease during the last month of pregnancy
r within 5 months after giving birth (1). The prognosis
or peripartum cardiomyopathy can be grim, with mor-
ality rates ranging from 15% to 56% (1,2). These
atients have a significant risk of thromboembolism,
trial fibrillation, persistent cardiomyopathy, and severe
r fatal recurrence with subsequent pregnancies (2,3).
rom the *Cardiovascular Center, Department of Medicine, and the †Department of
iostatistics, Medical College of Georgia, Augusta, Georgia; and the ‡Department of
edicine, University of Tennessee, Memphis, Tennessee. This work was supported
n part by National Institutes of Health Grant HL058496 (to Dr. Reed).c
Manuscript received June 3, 2009; revised manuscript received August 26, 2009,
ccepted September 21, 2009.ecent analysis suggests that the incidence of peripartum
ardiomyopathy may be increasing (4).
Peripartum cardiomyopathy was described 150 years
go, but the risk factors or causes have not been firmly
stablished (5,6). An early review of peripartum cardiomy-
pathy noted that “viral infections, autoimmune mecha-
isms, hormonal changes, genetic disorders and toxemia”
ere possible etiologies (7). Yet, despite a number of
nvestigations, no specific cause or pathophysiologic mech-
nism has been found that distinguishes peripartum cardio-
yopathy from other cardiomyopathies. For example, myo-
arditis has been identified in some patients with
eripartum cardiomyopathy, but myocarditis is also found
ith comparable frequency in patients with idiopathic
ilated cardiomyopathy (8–11). There is evidence for acti-
ation of the immune system in patients with peripartum
ardiomyopathy, but these findings are also found in other
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February 16, 2010:654–9 African-American Women and Peripartum Cardiomyopathyatients with HF (12,13). Viral deoxyribonucleic acid has
een identified in the hearts of patients with peripartum
ardiomyopathy, although the frequency was not different
rom controls, and other studies have shown conflicting
esults (14,15).
There is a striking variation in the frequency of peripar-
um cardiomyopathy around the world. An analysis of U.S.
ospital discharge data suggested a frequency of 31 women
er 100,000 deliveries (4). Other published estimates in the
.S. have ranged from 12 to 25 of 100,000 (16,17). A
omparable rate of 34 of 100,000 deliveries has been
eported in Malaysia (18). In contrast, rates per 100,000 as
igh as 334 in Haiti, 100 in South Africa, and 980 in
igeria have been reported (19–21). These countries differ
arkedly in factors, such as nutritional status and types of
nfections, that may affect the risk of peripartum cardiomy-
pathy (1,2). Although these incidence data suggest that
frican women have a greater risk for peripartum cardio-
yopathy, it is difficult to assess the relative risk of race and
nvironmental factors in racially homogenous populations
12,19,20). Studies in the U.S. have drawn different con-
lusions about whether race or ethnicity influences the risk
f peripartum cardiomyopathy. Recent hospital data have
uggested that peripartum cardiomyopathy is more frequent
mong African Americans than other groups (4,17). How-
ver, a seminal paper by Demakis (7) on peripartum
ardiomyopathy concluded that there was no association
ith race, and in other case series, the overwhelming
ajority of patients have been Caucasian (3,22).
One explanation for the discrepancy between reports is
hat peripartum cardiomyopathy is uncommon; to identify
redisposing factors for a rare condition requires observa-
ions from thousands of deliveries. For relatively rare con-
itions such as this, a case-control study provides an efficient
echanism for identifying risk factors. To determine if
frican-American race and other factors are associated with
n increased risk of developing peripartum cardiomyopathy,
e performed a case-control study at a regional medical
enter that provides care to a racially heterogeneous
opulation.
ethods
he study protocol was approved by the Medical College of
eorgia (MCG) institutional review board. The medical
ecords of all patients admitted to the MCG were screened
o identify cases between July 2003 and July 2008. To meet
he diagnosis for peripartum cardiomyopathy, all cases had
o satisfy the National Heart, Lung, and Blood Institute
riteria (1): 1) an ejection fraction45% by echocardiogram
r radionuclide ventriculography; 2) clinical symptoms of
F; 3) development of cardiac failure in the last month of
regnancy or within 5 months of delivery; 4) absence of
dentifiable cause of cardiac failure; and 5) absence of
ecognizable heart disease before the last month of preg-
ancy. Of 35 potential cases identified, 7 were excluded because they did not meet the
riteria for peripartum cardiomy-
pathy (2 had ejection fraction
45%, 1 was diagnosed 5
onths post-partum, 1 had hu-
an immunodeficiency virus,
nd 3 had another identifiable
ause of HF). For each case, 3
ealthy control patients were randomly selected from
omen who had delivered babies at MCG within the same
onth as the cases. No control patients were excluded. Data
ere extracted from a standardized clinical admission form
y using strictly defined criteria to minimize bias. Race or
thnic data was self-reported at the time of admission and
as indicated for all the cases or controls. For the other
ariables analyzed in this study, at least 1 data item was
issing in 18% of the sample.
tatistical analysis. The unadjusted odds ratios (ORs) of
eripartum cardiomyopathy were calculated for race (Afri-
an American vs. non–African American) and the following
isk factors: household income (estimated from 2000 census
emographic data by zip codes), number of pregnancies (live
irths and miscarriages), and age at delivery. Other factors
ncluded the presence or absence of hypertension, diabetes
ellitus, marital status at delivery, or the use of alcohol,
rugs, or cigarette smoking during pregnancy. Statistical
ests were 2-tailed with   0.05 level of significance.
The risk of peripartum cardiomyopathy was modeled
sing multivariable forward-selection binary logistic regres-
ion analysis using the following binary variables: African-
merican ethnicity, hypertension, drug use, married at time
f delivery, cigarette smoking during pregnancy, diabetes
ellitus, and alcohol use during pregnancy. The remaining
ariables were dichotomized using a median split for use in
he logistic regression analysis: number of pregnancies (2
s. 2), household income ($33,680 vs. $33,680), and
ge at delivery (24 years vs. 24 years). To further assess
he possibility of effect modification on the variables chosen
n the first regression analysis, an additional forward-
election logistic regression was performed using these
actors and 2-way interaction terms for of all of the factors.
inally, to minimize any effects of missing data, a stratified
nalysis was performed to analyze the effect of individual
isk factors on the relationship between African-American
ace and peripartum cardiomyopathy. This stratified analysis
ncluded a Breslow-Day test of homogeneity of ORs, a
antel-Haenszel estimate of a common OR across strata,
nd a Mantel-Haenszel test of OR unity for each factor
ombined across strata.
esults
o examine whether African-American descent was asso-
iated with a strong risk for peripartum cardiomyopathy, we
nalyzed the frequency of this disorder at our institution
Abbreviations
and Acronyms
HF  heart failure
MCG  Medical College of
Georgia
OR  odds ratioetween July 1, 2003, and July 31, 2008. When categorized
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African-American Women and Peripartum Cardiomyopathy February 16, 2010:654–9y race, the incidence of cases was 1 of 4,167 (or 24 of
00,000) deliveries for non–African Americans and 15 of
,412 (or 340 of 100,000) deliveries for African Americans.
ach case represented a unique individual. Analyzed in this
ashion, the OR for women of African-American descent
or having peripartum cardiomyopathy was 14.4-fold higher
han for non–African-American women (p 0.001). In our
nstitution, peripartum cardiomyopathy did not occur
mong women of Hispanic or other descent, although they
epresented a small proportion of the deliveries (6% His-
anic, and 5.2% other—Asian, Indian, or unidentified).
To assess the factors that may affect the relationship
etween African-American descent and peripartum cardio-
linical Characteristics ofases Comp red With C ntrolsTable 1 Clinical Characteristics ofCases Compared With Controls
Variable
Cases
(n  28)
Controls
(n  84)
Income, $ 1,000 29.3 10.7 33.8 9.5*
Gravidity 2.8 1.5 2.3 1.5
Age at delivery, yrs 26.3 5.2 24.5 5.5
Ejection fraction, % 24.6 9.8 —
ata represent mean  SD. *p  0.05.
nadjusted Odds Ratios for Peripartum CardiomyopathyTable 2 Unadjusted Odds Ratios for Peripartum Cardiomyopath
Variable Cases, n (%) Controls, n (%
Race
African American 26 (92.9) 38 (45.2)
Other 2 (7.1) 46 (54.8)
Hypertension
Yes 8 (28.6) 3 (3.6)
No 20 (71.4) 81 (96.4)
Drug use during pregnancy
Yes 3 (11.1) 2 (2.4)
No 24 (88.9) 82 (97.6)
Unmarried
Yes 20 (80.0) 38 (48.7)
No 5 (20.0) 40 (51.3)
Cigarettes during pregnancy
Yes 8 (29.6) 13 (15.5)
No 19 (70.4) 71 (84.5)
Diabetes mellitus
Yes 2 (7.1) 2 (2.4)
No 26 (92.9) 82 (97.6)
Number of pregnancies†
2 14 (58.3) 27 (32.5)
2 10 (41.7) 56 (67.5)
Household income†
$33,680 17 (65.4) 44 (56.4)
$33,680 9 (34.6) 34 (43.6)
Age at delivery, yrs†
24 14 (53.8) 35 (41.7)
24 12 (46.2) 49 (58.3)
Alcohol during pregnancy
Yes 1 (3.8) 5 (6.0)
No 25 (96.2) 79 (94.0)Significant p  0.05. †Based on median split.yopathy, we performed a case-control analysis of medical
ecords. When compared with controls in this study (Table 1),
ases had lower estimated household incomes (p  0.05).
owever, there were no significant differences between
ases and controls in number of pregnancies or the mother’s
ge at delivery (Table 1).
Case-control analysis of our data (Table 2) showed that
frican-American race increased the univariate odds of
eripartum cardiomyopathy 15.7-fold (p  0.001). Women
f African-American descent comprised 45.2% of our con-
rol subjects, but 92.9% of our peripartum cardiomyopathy
ases. Other factors associated with a significantly increased
nivariate odds (p  0.05) of peripartum cardiomyopathy
ere a history of hypertension (OR: 10.8), being unmarried
t the time of delivery (OR: 4.2), and having 2 or more
revious pregnancies (OR: 2.9).
Forward-selection multiple logistic regression was used to
xamine how race and other risk factors, in combination,
ffected the odds of developing peripartum cardiomyopathy.
n this analysis (Table 3), African-American ethnicity
emained a strong risk factor (OR: 31.5, p  0.005), which
merged first in the analysis. Cigarette smoking during
regnancy was also identified as a risk factor (OR: 6.0, p 
Odds Ratio p Value 95% Confidence Interval
15.7 0.001* 3.5–70.6
10.8 0.001* 2.6–44.4
5.1 0.083 0.8–32.4
4.2 0.009* 1.4–12.3
2.3 0.262 0.8–6.4
3.2 0.262 0.4–23.5
2.9 0.025* 1.1–7.4
1.5 0.422 0.6–3.7
1.6 0.277 0.6–4.0
0.6 0.682 0.1–5.7y
)
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February 16, 2010:654–9 African-American Women and Peripartum Cardiomyopathy.02). No other variables were added to the model, because
hey were not significant (p  0.05) explanatory factors. To
etermine if any other factors modified the effect of
frican-American ethnicity or smoking on peripartum car-
iomyopathy, another forward-selection regression was per-
ormed using all risk factor, 2-way interaction terms. None
f the 2-way interactions was significant, suggesting that no
ther factors modified the risk by these 2 variables. Since the
ultivariate adjusted OR for African-American ethnicity
OR: 31.5) was twice the estimated unadjusted OR (OR:
5.7), smoking may be a potential negative confounder of
he relationship of race to the development of peripartum
ardiomyopathy.
To further assess whether other variables confounded the
trong relationship between African-American descent and
eripartum cardiomyopathy, we performed a series of strat-
fied analyses, controlling for 1 confounder at a time, using
he Mantel-Haenszel statistic. African-American descent
emained a significant risk factor (OR: 12.7 to 29.1) for
eripartum cardiomyopathy despite stratification for all
ariables (Table 4). Indeed, the OR of African-American
thnicity was similar when stratified across all risk factors, as
ndicated by homogeneity tests. Thus, none of the other risk
actors explained the strong risk of African-American de-
cent for the development of peripartum cardiomyopathy.
iscussion
n this case-control study, African-American race was the most
mportant predictor of having peripartum cardiomyopathy,
ith an OR of 15.7 versus non–African-American patients. In
ultivariate regression and in stratified analysis, African-
merican descent remained a potent, significant risk factor
inal Statistics of theorward-Sele tion Logistic Regression AnalysisTable 3 Final Stat s of theForward-Selection Logistic Regression Analysis
Variable/Risk Factor p Value
Odds
Ratio
95% Confidence
Interval for OR
Race, African American vs. other 0.002* 31.5 3.6–277.6
Smoke cigarettes during pregnancy,
yes vs. no
0.017* 6.0 1.4–26.3
p  0.05.
OR  odds ratio.
Stratified Odds Ratio of Peripartum CardiomyopTable 4 Stratified Odds Ratio of Peripartum
Stratifying Variable
Household income,† $33,680 vs. $33,680
Unmarried, yes vs. no
Hypertension, yes vs. no
Diabetes mellitus, yes vs. no
Alcohol during pregnancy, yes vs. no
Drug use during pregnancy, yes vs. no
Cigarette smoking during pregnancy, yes vs. no
Number of pregnancies,† 2 vs. 2
Age at delivery,† 24 yrs vs. 24 yrs*Mantel-Haenszel common odds ratio (OR) for African-American race. †BaseOR: 31.5) for peripartum cardiomyopathy, even when the
otential effects of other risk factors were considered.
We examined other reports to calculate whether African-
merican race was also associated with an increased risk of
eripartum cardiomyopathy. An early, seminal study by
emakis et al. (16) at Cook County Hospital failed to
etect an increased risk for African-American women, but
heir calculation was flawed because it was based on cases
nd birth data from 2 different historical epochs (1947 to
967 and 1952 to 1965). However, examination of 2 large,
ore recent U.S. studies with data on race (Table 5) (4,17)
howed that African-American women had significantly
igher ORs (3.6 and 4.7) for having peripartum cardiomy-
pathy. Both reports were based on discharge diagnoses,
btained from the Kaiser Permanente system or the Na-
ional Hospital Discharge Study (4,17). The reliance of
hese studies solely on discharge data and specific Interna-
ional Classification of Diseases-Ninth Revision codes
ould, as the authors acknowledge, affect the detection of
ome patients who had peripartum cardiomyopathy, because
f errors in coding (17). Yet, despite the differences in study
esign and methodology, there is an important consistency
n our findings: the ORs for peripartum cardiomyopathy in
oth the studies by Brar et al. (17) (OR: 3.6) and Mielnic-
uk et al. (4) (OR: 4.7) fall within the 95% confidence
nterval (3.5 to 70.6) estimated in our study.
Worldwide, the frequency of peripartum cardiomyopathy
s highest where a large proportion of the women were of
frican descent such as Nigeria, Haiti, South Africa, and
his study (Fig. 1) (19–21). The lowest frequency of
eripartum cardiomyopathy has been reported in studies
here women of African descent were less common, such as
for African Americansiomyopathy for African Americans
95% Confidence Interval p Value
3.2–147.5 0.001‡
2.4–87.2 0.001‡
2.9–55.3 0.001‡
3.4–68.6 0.001‡
3.8–221.3 0.001‡
3.2–63.7 0.001‡
3.3–54.6 0.001‡
2.8–59.2 0.001‡
3.1–63.2 0.001‡
elative Risk of African-American Descent forripartum Cardiomyopathy in This andther Studies
Table 5
Relative Risk of African-American Descent for
Peripartum Cardiomyopathy in This and
Other Studies
Source (Ref. #) Period
Number of
Cases OR
95% Confidence
Interval
This study* 2003–2008 28 15.7† 3.5–70.6
Kaiser-CA (17)* 1996–2005 60 3.6† 2.0–6.2
U.S. hospitals (4)* 1990–2002 10,898 4.7† 4.5–4.9
Odds ratio (OR) calculated for African Americans versus non–African Americans on the basis of
ata available in each report. †p  0.001.athyCard
OR*
21.9
14.6
12.7
15.3
29.1
14.2
13.5
12.9
14.0d on median split. ‡p  0.05.
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African-American Women and Peripartum Cardiomyopathy February 16, 2010:654–9he U.S. Hospital Discharge Study, the Kaiser-Southern
alifornia report, and a series in Malaysia (4,17,18,22). The
ighest reported incidence is in Nigeria, at 980 of 100,000
eliveries (20). This very high incidence may be related to a
ocal custom of ingesting salt in the post-partum period,
hich increased the detection of peripartum cardiomyopa-
hy by increasing clinical HF symptoms (20). Desai et al.
21) found a case incidence of 100 of 100,000 deliveries in
outh Africa. Fett et al. (19) has reported an incidence in a
redominately rural population in Haiti of 334 of 100,000
eliveries. The incidence of peripartum cardiomyopathy in
ur population as a whole was 185 of 100,000 deliveries,
hich is substantially higher than previously reported in the
.S. (Fig. 1). However, it is striking that the incidence
mong African Americans in our study was 340 of 100,000,
number quite similar to the 334 of 100,000 deliveries
eported in Haiti (19). In addition to African-American
escent, other risk factors were identified for the develop-
ent of peripartum cardiomyopathy. Among these other
ignificant univariate risk factors was a history of hyperten-
ion (OR: 10.8), marital status (OR: 4.2), and having 2
regnancies (OR: 2.9). Similar to case series from Haiti (19)
nd South Africa (21), we did not confirm the hypothesis
hat maternal age increases the risk of having peripartum
ardiomyopathy. Although hypertension is common in
eripartum cardiomyopathy (2% to 43% of patients), this is
he first study to demonstrate that hypertension confers a
ignificant increase in risk (4,20–22). Certainly, uncon-
rolled, severe hypertension can lead to cardiac dysfunction.
till, none of our patients had known hypertensive heart
isease or evidence of left ventricular hypertrophy on echo-
ardiogram. Moreover, in the multivariable logistic regres-
ion analysis, race and smoking were the only significant
Figure 1
Frequency of Peripartum
Cardiomyopathy in Augusta, Georgia,
Study and Other Studies per 100,000 Deliveries
The frequency of peripartum cardiomyopathy as reported previously in the liter-
ature is illustrated. Traditionally, studies from the U.S. have reported a much
lower frequency than in other parts of the world. This is the first U.S. study to
demonstrate a frequency of peripartum cardiomyopathy similar to that seen in
Haiti and Africa.redictors; hypertension was not. fCase-control studies are among the most powerful meth-
ds for identifying risk factors associated with uncommon
iseases or conditions. However, our hospital-based study
ay not have detected the occurrence of peripartum cardio-
yopathy in women who were mildly affected and did not
equire hospital admission. Still, significant underdetection
eems implausible, as the incidence of peripartum cardio-
yopathy per 100,000 deliveries in this study was higher
han in other U.S. reports, although it was within the range
f other studies in which the majority of women were of
frican descent.
To be certain that cases were not missed, we separately
eviewed 3 years of hospital records for women of child-
earing age who were admitted with HF and found no new
ases. In analyzing our data, we were careful to be certain
hat the link between African-American descent and car-
iomyopathy was not due to biased detection. Biased
etection seems doubtful because: 1) race was self-reported
nd available for all cases and controls; 2) cardiomyopathy
as independently confirmed by echocardiography; and
) African-American descent had not previously been es-
ablished as a risk factor for this condition. In addition, we
sed both the Mantel-Haenszel and multiple logistic re-
ression techniques to determine whether the increased risk
f peripartum cardiomyopathy in African-American women
ould be attributed to other variables.
These analyses confirmed that the risk of peripartum
ardiomyopathy was consistently elevated when the effects
f all other variables were considered.
onclusions
hese data and an analysis of previous reports provide
trong, consistent evidence that the risk of peripartum
ardiomyopathy is increased among women of African
escent. It is important to consider whether the increased
isk is due to genetic factors, environmental factors, or both.
n future studies, more precise definitions of race and
escent may better identify those at greatest risk for peri-
artum cardiomyopathy. As Yancy (24) has pointed out,
race, intermarriage, and reproduction are decidedly variable
n North America,” yet certain hypertensive conditions such
s end-stage renal disease, left ventricular hypertrophy, and
o forth, are more common among African-American
atients. Consistent with that notion, our study found that
ypertension was a significant univariate risk factor for the
evelopment of peripartum cardiomyopathy. Women with
ardiomyopathy had a lower estimated family income than
ontrol women. Other factors associated with an increased
nivariate risk of peripartum cardiomyopathy included be-
ng unmarried at the time of delivery, and having 2 or more
revious pregnancies. Although not significant in the uni-
ariate analysis, cigarette smoking during pregnancy was a
ignificant risk factor in the multivariate logistic regression
nalysis. However, in the stratified analysis, none of these
actors could explain solely the increased risk for this
d
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February 16, 2010:654–9 African-American Women and Peripartum Cardiomyopathyisorder among African-American women. Still, our power
o detect multivariate interactions that may affect the
ssociation we found between African-American descent
nd peripartum cardiomyopathy may have been limited by
he relatively small size of our sample. Thus, we are unable
o determine in this study whether genetic factors of race, or
ther complex environmental, social, economic, or other
actors that are linked to race, account for the increased risk
f peripartum cardiomyopathy. Further research is needed
o better identify women at increased risk of cardiomyopa-
hy and to develop strategies for prevention.
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